Icon (ICLR) Change in Acquisitions & Divestments (2009 - 2026)
Icon's (ICLR) quarterly Change in Acquisitions & Divestments came in at $4.5 million in Q2 2026, up 877.73% year-over-year from $458000.0 in Q2 2025, and up 1602.66% quarter-over-quarter from $263000.0 in Q1 2026.
Powered by 
Analysis
Icon (ICLR) Change in Acquisitions & Divestments (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Change in Acquisitions & Divestments for 18 consecutive years, with $4.5 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Acquisitions & Divestments rose 877.73% year-over-year to $4.5 million in Q2 2026; TTM through Jun 2026 was $13.3 million, a 606.55% increase from a year earlier, with the FY2025 full-year figure at $9.1 million, up 237.88% from the prior year.
- Change in Acquisitions & Divestments was $4.5 million for Q2 2026 at Icon, up from $263000.0 in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $7.0 million in Q4 2025 and troughed at -$422000.0 in Q2 2023.
- A 5-year average of $1.1 million and a median of $360500.0 in 2025 frame the typical range for Change in Acquisitions & Divestments.
- Across the five-year window, Change in Acquisitions & Divestments slumped 339.58% in 2023 and soared 36610.53% in 2025, its largest moves.
- Over 5 years, Change in Acquisitions & Divestments stood at $1.9 million in 2022, then plunged by 112.64% to -$241000.0 in 2023, then jumped by 107.88% to $19000.0 in 2024, then soared by 36610.53% to $7.0 million in 2025, then tumbled by 35.8% to $4.5 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $4.5 million (Q2 2026), $263000.0 (Q1 2026), and $7.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.48 Mn |
| Mar 31, 2026 | 263,000.00 |
| Dec 31, 2025 | 6.98 Mn |
| Sep 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | 458,000.00 |
| Mar 31, 2025 | 103,000.00 |
| Dec 31, 2024 | 19,000.00 |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.37 Mn |
| Dec 31, 2023 | -241,000.00 |
| Sep 30, 2023 | -60,000.00 |
| Jun 30, 2023 | -422,000.00 |
| Mar 31, 2023 | 482,000.00 |
| Dec 31, 2022 | 1.91 Mn |
| Jun 30, 2022 | -96,000.00 |
| Mar 31, 2022 | 96,000.00 |
| Dec 31, 2021 | 480,000.00 |
| Sep 30, 2021 | 17,000.00 |
| Jun 30, 2020 | -1,000.00 |
| Mar 31, 2020 | 47.90 Mn |